DNA content and other factors associated with ten-year survival after resection of pancreatic carcinoma

Journal of Surgical Oncology

Volumn 67, Issue 3, 1998, Pages 151-159

  Allison, David C ^a,b   Piantadosi, Steven ^a   Hruban, Ralph H ^a   Dooley, William C ^a   Fishman, Elliot K ^a   Yeo, Charles J ^a   Lillemoe, Keith D ^a   Pitt, Henry A ^a   Lin, Paul ^a   Cameron, John L ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MEDICAL COLLEGE OF OHIO   (United States)

Author keywords

DNA; Long term survival; Pancreatic cancer

Indexed keywords

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CIGARETTE SMOKING; DNA CONTENT; FEMALE; FOLLOW UP; HEALTH HAZARD; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; ONCOGENE K RAS; PANCREAS CARCINOMA; PRIORITY JOURNAL; RISK FACTOR; TUMOR LOCALIZATION; TUMOR VOLUME;

ADENOCARCINOMA; DNA, NEOPLASM; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; PANCREATECTOMY; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SMOKING; SURVIVAL RATE; SURVIVORS;

EID: 0031918491     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199803)67:3<151::AID-JSO2>3.0.CO;2-8     Document Type: Article

References (58)

1. Crile G: The advantages of bypass operations over radical pancreatoduodenectomy in the treatment of pancreatic carcinoma. Surg Gynecol Obstet 1970;130:1049-1053.
2. Shapiro TM: Adenocarcinoma of the pancreas: A statistical analysis of biliary bypass vs. Whipple resection in good risk patients. Ann Surg 1975;182:715-721.
3. Gudjonsson B, Livstone EM, Spiro HM: Cancer of the pancreas. Diagnostic accuracy and survival statistics. Cancer 1978;42:2494-2506.
4. Van Heerden JA, ReMine WH, Wieland LH, et al: Total pancreatectomy for ductal adenocarcinoma of the pancreas. Am J Surg 1981;142:308-311.
5. Herter FP, Cooperman AM, Ahlborn TN, Antinori C: Surgical experience with pancreatic and periampullary cancer. Ann Surg 1982;195:274-281.
6. Piorkowski RJ, Blievernicht SW, Lawrence W, et al.: Pancreatic and periampullary carcinoma. Experience with 200 patients over a 12 year period. Am J Surg 1982;143:189-193.
7. Warren KW, Christophi C, Armendariz R, Basu S: Current trends in the diagnosis and treatment of carcinoma of the pancreas. Am J Surg 1983;145:813-818.
8. Grace PA, Pitt HA, Tompkins RK, et al.: Decreased morbidity and mortality after pancreatoduodenectomy. Am J Surg 1986;151: 141-149.
9. Jones BA, Langer B, Taylor BR, Girotti M: Periampullary tumors: Which ones should be resected? Am J Surg 1985;149:46-51.
10. Connolly MM, Dawson PJ, Michelassi F, et al.: Survival in 1001 patients with carcinoma of the pancreas. Ann Surg 1987;206:366-373.
11. Gudjonsson B: Cancer of the pancreas: 50 years of surgery. Cancer 1987;60:2284-2303.
12. Bramhall SR, Allum WH, Jones AG, et al.: Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: An epidemiological study. Br J Surg 1995;82:111-115.
13. Braasch JW, Deziel DJ, Rossi RL, et al.: Pyloric and gastric preserving pancreatic resection: Experience with 87 patients. Ann Surg 1986;204:411-418.
14. Crist DW, Sitzmann JV, Cameron JL: Improved hospital morbidity, mortality, and survival after the Whipple procedure. Ann Surg 1987;206:358-365.
15. Trede M, Schwall G, Saeger HD: Survival after pancreatoduodenectomy: 118 consecutive resections without an operative mortality. Ann Surg 1990:211:447-458.
16. Cameron JL, Crist DW, Sitzmann JV, et al.: Factors influencing survival after pancreatoduodenectomy for pancreatic cancer. Am J Surg 1991;161:120-125.
17. Delcore R, Thomas JH, Hermreck AS: Pancreaticoduodenectomy for malignant pancreatic and periampullary neoplasms in elderly patients. Am J Surg 1991;162:532-536.
18. Crist DW, Cameron JL: The current status of the Whipple operation for periampullary carcinoma. Adv Surg 1992;25:21-49.
19. Allison DC, Bose KK, Hruban RH, et al.: Pancreatic cancer cell DNA content correlates with long-term survival after pancreaticoduodenectomy. Ann Surg 1991;214:648-656.
20. Geer RJ, Brennan MF: Prognostic indictors for survival after resection of pancreatic adenocarcinoma. Am J Surg 1993;165:68-73.
21. Willett CG, Lewandrowski K, Warshaw AL, et al.: Resection margins in carcinoma of the head of the pancreas: Implications for radiation therapy. Ann Surg 1993;217:144-148.
22. Allema JH, Reinders ME, van Gulik TM, et al.: Prognostic factors for survival after pancreaticoduodenectomy for patients with carcinoma of the pancreatic head region. Cancer 1995;75:2069-2076.
23. Nitecki SS, Sarr MG, Colby TV, van Heerden JA: Long-term survival after resection for ductal adenocarcinoma of the pancreas. Is it really improving? Ann Surg 1995;221:59-66.
24. Yeo CJ, Cameron JL, Lillemoe KD, et al.: Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-733.
25. Conlon KC, Klimstra DC, Brennan MJ: Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. Ann Surg 1996;223:273-279.
26. Warshaw AL, Fernandez-del Castillo C: Author's reply. N Engl J Med 1992;326:1782.
27. Warshaw AL: Pancreatic surgery. A paradigm for progress in the age of the bottom line. Arch Surg 1995;130:240-246.
28. Hirayama T: Epidemiology of pancreatic cancer in Japan. Jpn J Clin Oncol 1989;19:208-215.
29. Warshaw AL, Fernandez-del Castillo C: Pancreatic carcinoma. N Engl J Med 1992;326:455-465.
30. Gold EB, Gordis L, Diener M, et al.: Diet and other risk factors for cancer of the pancreas. Cancer 1985;55:460-467.
31. Velema JP, Walker AM, Gold EB: Alcohol and pancreatic cancer: Insufficient epidemiologic evidence for a causal relationship. Epidemiol Rev 1986;8:28-41.
32. Topal MD: DNA repair, oncogenes, and carcinogenesis. Carcinogenesis 1988;9:691-696.
33. Cerny WL, Mangold KA, Scarpelli DG: K-ras mutation is an early event in pancreatic duct carcinogenesis in the Syrian golden hamster. Cancer Res 1992;52:4507-4513.
34. Hruban RH, van Mansfeld AD, Offerhaus GJA, et al.: K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993;143:545-554.
35. Gold EB: Epidemiology of and risk factors for pancreatic cancer. Surg Clin North Am 1995;75:819-843.
36. DiGiuseppe JA, Yeo CJ, Hruban RH: Molecular biology and the diagnosis and treatment of adenocarcinoma of the pancreas. Adv Anat Pathol 1996;3:139-155.
37. Porschen R, Remy U, Bevers G, et al.: Prognostic significance of DNA ploidy in adenocarcinoma of the pancreas. A flow cytometric study of paraffin-embedded specimens. Cancer 1993;71:3846-3850.
38. Bottger TC, Storkel S, Wellek S, et al.: Factors influencing survival after resection of pancreatic cancer. A DNA analysis and histomorphologic study. Cancer 1994;73:63-73.
39. Medley DW, Friedlander ML, Taylor IW, et al.: Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem 1983;31: 1333-1335.
40. Allison DC, Lawrence GN, Ridolpho PF, et al.: Increased accuracy and speed of absorption cytometric DNA measurements by automatic corrections for nuclear darkness. Cytometry 1984;5: 217-227.
41. Allison DC, Chakerian M, Ridolpho P, et al.: Combined flow and absorption cytometric DNA measurements of (3H)thymidine-labelled tumour cells. Cell Tissue Kinet 1987;20:273-290.
42. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
43. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22: 719-748.
44. Cox DR: Regression models and life tables. J R Stat Soc B 1972; 34:187-220.
45. Bose KK, Allison DC, Hruban RH, et al.: A comparison of flow cytometric and absorption cytometric DNA values as prognostic indicators for pancreatic carcinoma. Cancer 1993;71:691-700.
46. Allison DC, Mayall BH, Levin J: Comparison of absorption measurements of DNA stain content utilizing video and scanning image cytometers. Cytometry 1988;9:573-578.
47. Yeo CJ, Abrams RA, Grochow LB, et al.: Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival. Ann Surg 1997;225:621-636.
48. Evans DB, Frazier ML, Charnsangavej C, et al.: Molecular diagnosis of exocrine pancreatic cancer using a percutaneous technique. Ann Surg Oncol 1996;3:241-246.
49. Ballard RB, Hoffman JP, Guttman MC, et al.: How accurate is size measurement of pancreas cancer masses by computed axial tomography (CT) scanning? Am Surg 1995;61:686-691.
50. Ishikawa O, Ohigashi H, Sasaki Y, et al.: Practical usefulness of lymphatic and connective tissue clearance for the carcinoma of the pancreas head. Ann Surg 1988;208:215-220.
51. Manabe T, Ohshio G, Baba N, et al.: Radical pancreatectomy for ductal carcinoma of the head of the pancreas. Cancer 1989;64: 1132-1137.
52. Ishikawa O, Ohigashi H, Imaoka S, et al.: Preoperative indications for extended pancreatectomy for locally advanced pancreas cancer involving the portal vein. Ann Surg 1992;215:231-236.
53. Satake K, Nishiwaki H, Yokomatsu H, et al.: Surgical curability and prognosis for standard versus extended resection for T1 carcinoma of the pancreas. Surg Gynecol Obstet 1992;175:259-265.
54. Henne-Bruns D, Kremer B, Meyer-Pannwitt U, et al.: Partial duodenopancreatectomy with radical lymphadenectomy in patients with pancreatic and periampullary carcinomas: Initial results. Hepato-Gastroenterology 1993;40:145-149.
55. Ishikawa O: Surgical technique, curability, and postoperative quality of life in an extended pancreatectomy for adenocarcinoma of the pancreas. Hepato-Gastroenterology 1996;43:320-325.
56. Nagakawa T, Nagamori M, Futakami F, et al.: Results of extensive surgery for pancreatic carcinoma. Cancer 1996;77:640-645.
57. Bakkevold KE, Kambestad B: Morbidity and mortality after radical and palliative pancreatic cancer surgery: Risk factors influencing the short-term results. Ann Surg 1993;217:356-368.
58. Lillemoe KD: Current management of pancreatic carcinoma. Ann Surg 1995; 221:133-148.